351 related articles for article (PubMed ID: 33000761)
1. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic diet as a successful early treatment modality for SCN2A mutation.
Turkdogan D; Thomas G; Demirel B
Brain Dev; 2019 Apr; 41(4):389-391. PubMed ID: 30415926
[TBL] [Abstract][Full Text] [Related]
3. SCN2A mutation in an infant presenting with migrating focal seizures and infantile spasm responsive to a ketogenic diet.
Su DJ; Lu JF; Lin LJ; Liang JS; Hung KL
Brain Dev; 2018 Sep; 40(8):724-727. PubMed ID: 29625812
[TBL] [Abstract][Full Text] [Related]
4. Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence.
Melikishvili G; Dulac O; Gataullina S
Epilepsy Behav; 2020 Oct; 111():107187. PubMed ID: 32603808
[TBL] [Abstract][Full Text] [Related]
5. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.
Howell KB; McMahon JM; Carvill GL; Tambunan D; Mackay MT; Rodriguez-Casero V; Webster R; Clark D; Freeman JL; Calvert S; Olson HE; Mandelstam S; Poduri A; Mefford HC; Harvey AS; Scheffer IE
Neurology; 2015 Sep; 85(11):958-66. PubMed ID: 26291284
[TBL] [Abstract][Full Text] [Related]
6. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
7. [Phenotype study of SCN2A gene related epilepsy].
Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
[No Abstract] [Full Text] [Related]
8. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy.
Datta AN; Bahi-Buisson N; Bienvenu T; Buerki SE; Gardiner F; Cross JH; Heron B; Kaminska A; Korff CM; Lepine A; Lesca G; McTague A; Mefford HC; Mignot C; Milh M; Piton A; Pressler RM; Ruf S; Sadleir LG; de Saint Martin A; Van Gassen K; Verbeek NE; Ville D; Villeneuve N; Zacher P; Scheffer IE; Lemke JR
Epilepsia; 2021 Feb; 62(2):325-334. PubMed ID: 33410528
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide for SCN2A-related intractable neonatal and infantile seizures.
Flor-Hirsch H; Heyman E; Livneh A; Reish O; Watemberg N; Litmanovits I; Ben Sason Lilli A; Lev D; Lerman Sagie T; Bassan H
Epileptic Disord; 2018 Oct; 20(5):440-446. PubMed ID: 30361185
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy.
Dilena R; Striano P; Gennaro E; Bassi L; Olivotto S; Tadini L; Mosca F; Barbieri S; Zara F; Fumagalli M
Brain Dev; 2017 Apr; 39(4):345-348. PubMed ID: 27876397
[TBL] [Abstract][Full Text] [Related]
13. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy.
Ko A; Youn SE; Kim SH; Lee JS; Kim S; Choi JR; Kim HD; Lee ST; Kang HC
Epilepsy Res; 2018 Mar; 141():48-55. PubMed ID: 29455050
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
Wolff M; Brunklaus A; Zuberi SM
Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy.
Miao P; Tang S; Ye J; Wang J; Lou Y; Zhang B; Xu X; Chen X; Li Y; Feng J
Mol Genet Genomic Med; 2020 Jul; 8(7):e1250. PubMed ID: 32400968
[TBL] [Abstract][Full Text] [Related]
17.
Yang XR; Ginjupalli VKM; Theriault O; Poulin H; Appendino JP; Au PYB; Chahine M
J Neurophysiol; 2022 May; 127(5):1388-1397. PubMed ID: 35417276
[TBL] [Abstract][Full Text] [Related]
18. Novel SCN2A mutation in a family associated with juvenile-onset myoclonus: Case report.
Huang Q; Yu L; Ma M; Qi H; Wu Y
Medicine (Baltimore); 2019 Feb; 98(8):e14698. PubMed ID: 30813219
[TBL] [Abstract][Full Text] [Related]
19. Infantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine.
Foster LA; Johnson MR; MacDonald JT; Karachunski PI; Henry TR; Nascene DR; Moran BP; Raymond GV
Pediatr Neurol; 2017 Jan; 66():108-111. PubMed ID: 27867041
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia].
Guan J; Du KX; Dong Y; Li L; Song PP; Gong H; Zhang XL; Jia TM
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):51-55. PubMed ID: 34986624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
